AI assistant
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017
Oct 4, 2017
30849_dirs_2017-10-04_662d06a6-4ec8-4c39-a62b-92a1cba6cc5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04
Reporting Person: MPM BIOVENTURES V, L.P. (10% Owner)
Reporting Person: EVNIN LUKE (10% Owner)
Reporting Person: GADICKE ANSBERT (10% Owner)
Reporting Person: MPM ASSET MANAGEMENT INVESTORS BV5 LLC (10% Owner)
Reporting Person: MPM BIOVENTURES V GP LLC (10% Owner)
Reporting Person: MPM BIOVENTURES V LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 29378 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (834441) | Indirect | ||
| Series A-1 Junior Preferred Stock | $ | Common Stock (1732573) | Indirect |
Footnotes
F1: Reflects a 1-for-9.17 reverse split effective as of September 29, 2017.
F2: The shares are held as follows: 28,280 by MPM BioVentures V, L.P. ("BV V") and 1,098 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. Mr. Foley is a director of the Issuer and has separately filed a Form 3. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
F3: Each share of Series A Preferred Stock and Series A-1 Junior Preferred Stock is convertible into 0.10905125 of a share of Common Stock without payment of further consideration and will automatically convert into 0.10905125 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The
shares have no expiration date.
F4: The shares are held as follows: 803,237 by BV V and 31,204 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
F5: The shares are held as follows: 1,667,782 by BV V and 64,791 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.